Segall Bryant & Hamill’s Niagen Bioscience, Inc. Common Stock NAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-17,500
| Closed | -$57K | – | 826 |
|
|
2020
Q1 | $57K | Buy |
17,500
+2,000
| +13% | +$6.51K | ﹤0.01% | 772 |
|
|
2019
Q4 | $67K | Sell |
15,500
-5,500
| -26% | -$23.8K | ﹤0.01% | 809 |
|
|
2019
Q3 | $83K | Hold |
21,000
| – | – | ﹤0.01% | 807 |
|
|
2019
Q2 | $98K | Buy |
21,000
+1,000
| +5% | +$4.67K | ﹤0.01% | 798 |
|
|
2019
Q1 | $84K | Sell |
20,000
-2,000
| -9% | -$8.4K | ﹤0.01% | 808 |
|
|
2018
Q4 | $75K | Hold |
22,000
| – | – | ﹤0.01% | 805 |
|
|
2018
Q3 | $94K | Sell |
22,000
-3,000
| -12% | -$12.8K | ﹤0.01% | 829 |
|
|
2018
Q2 | $93K | Hold |
25,000
| – | – | ﹤0.01% | 837 |
|
|
2018
Q1 | $105K | Hold |
25,000
| – | – | ﹤0.01% | 597 |
|
|
2017
Q4 | $147K | Sell |
25,000
-5,000
| -17% | -$29.4K | ﹤0.01% | 557 |
|
|
2017
Q3 | $129K | Sell |
30,000
-8,834
| -23% | -$38K | ﹤0.01% | 561 |
|
|
2017
Q2 | $148K | Hold |
38,834
| – | – | ﹤0.01% | 543 |
|
|
2017
Q1 | $104K | Buy |
38,834
+133
| +0.3% | +$356 | ﹤0.01% | 541 |
|
|
2016
Q4 | $128K | Hold |
38,701
| – | – | ﹤0.01% | 529 |
|
|
2016
Q3 | $115K | Buy |
38,701
+1,034
| +3% | +$3.07K | ﹤0.01% | 540 |
|
|
2016
Q2 | $156K | Buy |
+37,667
| New | +$156K | ﹤0.01% | 532 |
|